Related articles
MedTech Company
Stroke diagnostics innovator Wellumio secures $7.2m first close to accelerate clinical milestones
Strong investor demand for Wellumio’s portable brain scan technology drives first close of pre-Series A round, with final allocations available on the same terms WELLINGTON, New Zealand, February 11, 2026 - Wellumio, a New Zealand-based medical technology company developing a portable neuroimaging device for rapid, point-of-care stroke detection, has raised $7.28 million in the first close of its pre-Series A funding round to accelerate key clinical milestones.
MedTech Company
Alimetry gets FDA nod for AI-powered update to its gastric device
It opens up the opportunity for a more wearable next generation for products.
NZ Medtech Scene
Wearable health platform Symply ramps up for 2026 lanuch
The startup is close to securing a strategic US investor that would allow the co-funders to sidestep local VC seed money.